14th edition

Format
HYBRID

December 2nd & 3rd, 2025

IN-PERSON | STRASBOURG

December 8th ,2025

ONLINE MEETINGS

Stand

2020 Edition

InnoSer

Belgium

Founded in 2012, InnoSer is an innovative and dynamic contract research organization (CRO) that supports the discovery and preclinical development of drugs. InnoSer’s offerings include a unique, conditional knockout model for ADPKD (nephrology) in mice, a patient derived screening-platform for oncology: PDX/O, and a first-in-class, validated, midbrain-organoid platform to screen drugs for Parkinson’s disease. Also, InnoSer provides pathology- and in-vivo research services including colony management, cryopreservation, sanitation/rederivation.

Scroll to Top
  • No products in the cart.